Seer Appoints Rachel Haurwitz, Ph.D., to its Board of Directors
November 8, 2021
REDWOOD CITY, Calif. -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Rachel Haurwitz, Ph.D. to serve on its Board of Directors, effective November 8, 2021. Dr. Haurwitz is currently CEO of Caribou Biosciences, Inc. a clinical-stage biopharmaceutical company developing genome-edited off-the-shelf immune [...]
QIAGEN commits to reduce carbon emissions by setting science-based target to reach net zero by 2050
November 8, 2021
Joins “Business Ambition for 1.5˚C” campaign of the Science-Based Targets initiative Commitment to achieve by 2030 at least 40% reduction in Scope 1 and 2 emissions, and at least 10% reduction in Scope 3 emissions, on way to reach net-zero carbon emissions by 2050 VENLO, Netherlands & HILDEN, Germany -- QIAGEN N.V. (NYSE: QGEN; Frankfurt [...]
November 8, 2021
Azenta Life Sciences to provide comprehensive vaccine inventory management CHELMSFORD, Mass. -- Brooks Automation, Inc. (Nasdaq: BRKS) today announced that its newly branded Azenta Life Sciences business has been contracted by QTC Management, Inc., a Leidos company (NYSE: LDOS), to provide the storage and distribution of vaccines to the U.S. Department of Defense. Earlier this year, QTC [...]
ASURAGEN LAUNCHES NEW KIT TO ENABLE BROADER COVERAGE OF GENE VARIANTS LINKED TO CYSTIC FIBROSIS
November 8, 2021
CFTR testing kit with streamlined workflow delivers reliable results in less than five hours MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Asuragen, Inc., a Bio-Techne brand, has launched a new kit to detect pathogenic variants in the CFTR gene. The AmplideX® PCR/CE CFTR Kit, intended for research use only, provides broader coverage of the diverse U.S. population1,2 than any [...]
Alpha MOS and FlavorActiV Partnership Announced
November 8, 2021
Taking Food and Beverage Sensory to the Next Level FlavorActiV and Alpha MOS are pleased to announce their strategic partnership. Officially starting on 1st November 2021, the agreement allows FlavorActiV the responsibilities of the followings: Sale, distribution and support of E-nose to selected Key Accounts in EMEA region, with additional countries to be added in 2022. [...]
November 8, 2021
JEOL Ltd. (President & COO Izumi Oi) announces the development and release of a new Scanning Electron Microscope (SEM), the JSM-IT510 series, in November 2021. Product Development Background Scanning electron microscopes are used in a wide range of fields, such as nanotechnology, metals, semiconductors, ceramics, medicine, and biology. In addition, SEM applications are expanding to [...]
ATS Acquires Biopharma Processing, Laboratory Equipment and Labware Provider SP Industries
November 7, 2021
CAMBRIDGE, ON - ATS Automation Tooling Systems Inc. (TSX: ATA) ("ATS" or the "Company"), an industry-leading automation solutions provider, today announced it has entered into a definitive agreement to acquire SP Industries, Inc. ("SP"), a designer and manufacturer of high-grade biopharma processing equipment, life sciences equipment, and lab apparatus products for US$445 million (~C$550 million), subject to customary [...]
Qlucore approved for listing on Nasdaq First North Growth Market
November 5, 2021
Qlucore AB (public) (“Qlucore” or “Company”) has today received approval of the application for listing of Qlucore shares on the Nasdaq First North Growth Market. The first day of trading of the shares will be 5th November 2021. Trading will be done with the ticker QCORE. "This paves the way for a new phase in [...]
Novel Pharma Drug Development Workflow Using Advanced DNP-NMR
November 5, 2021
GOTHENBERG, Sweden – Bruker today announced that it is collaborating with AstraZeneca to bring new state-of-the-art technology to a major Swedish national research center for drug development. Building on the AstraZeneca strategy of innovation through global partnerships, a collaboration between the Swedish NMR Center at the University of Gothenburg and AstraZeneca now offers advanced dynamic [...]
Repligen Releases Inaugural Sustainability Report
November 5, 2021
Sets Baseline and Provides SASB, GRI Core and SDG Disclosures WALTHAM, Mass. -- Repligen Corporation (NASDAQ: RGEN) today released its inaugural sustainability report, available on the Company’s website. Repligen’s 2020 Sustainability Report provides an overview of the Company’s environmental, social and governance (ESG) performance in 2020 and into 2021, and provides disclosures aligned to three [...]

